Suppr超能文献

血浆 microRNAs 是胆碱和叶酸缺乏饮食诱导小鼠肝损伤严重程度的菌株间差异的敏感指标。

Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a choline- and folate-deficient diet.

机构信息

Division of Biochemical Toxicology, National Center for Toxicological Research, Jefferson, AR 72079, USA.

出版信息

Toxicol Appl Pharmacol. 2012 Jul 1;262(1):52-9. doi: 10.1016/j.taap.2012.04.018. Epub 2012 Apr 24.

Abstract

MicroRNAs (miRNAs) are a class of small, conserved, tissue-specific regulatory non-coding RNAs that modulate a variety of biological processes and play a fundamental role in the pathogenesis of major human diseases, including nonalcoholic fatty liver disease (NAFLD). However, the association between inter-individual differences in susceptibility to NAFLD and altered miRNA expression is largely unknown. In view of this, the goals of the present study were (i) to determine whether or not individual differences in the extent of NAFLD-induced liver injury are associated with altered miRNA expression, and (ii) assess if circulating blood miRNAs may be used as potential biomarkers for the noninvasive evaluation of the severity of NAFLD. A panel of seven genetically diverse strains of inbred male mice (A/J, C57BL/6J, C3H/HeJ, 129S/SvImJ, CAST/EiJ, PWK/PhJ, and WSB/EiJ) were fed a choline- and folate-deficient (CFD) diet for 12weeks. This diet induced liver injury in all mouse strains; however, the extent of NAFLD-associated pathomorphological changes in the livers was strain-specific, with A/J, C57BL/6J, and C3H/HeJ mice being the least sensitive and WSB/EiJ mice being the most sensitive. The morphological changes in the livers were accompanied by differences in the levels of hepatic and plasma miRNAs. The levels of circulating miR-34a, miR-122, miR-181a, miR-192, and miR-200b miRNAs were significantly correlated with a severity of NAFLD-specific liver pathomorphological features, with the strongest correlation occurring with miR-34a. These observations suggest that the plasma levels of miRNAs may be used as biomarkers for noninvasive monitoring the extent of NAFLD-associated liver injury and susceptibility to NAFLD.

摘要

微小 RNA(miRNA)是一类小的、保守的、组织特异性的调节性非编码 RNA,它们调节多种生物学过程,在包括非酒精性脂肪性肝病(NAFLD)在内的多种人类重大疾病的发病机制中发挥着基本作用。然而,个体对 NAFLD 的易感性差异与 miRNA 表达改变之间的关联在很大程度上尚不清楚。鉴于此,本研究的目的是:(i)确定 NAFLD 诱导的肝损伤程度的个体差异是否与 miRNA 表达改变相关;(ii)评估循环血液 miRNA 是否可作为非侵入性评估 NAFLD 严重程度的潜在生物标志物。使用一组七种遗传背景不同的近交雄性小鼠(A/J、C57BL/6J、C3H/HeJ、129S/SvImJ、CAST/EiJ、PWK/PhJ 和 WSB/EiJ)进行实验,这些小鼠喂食胆碱和叶酸缺乏(CFD)饮食 12 周。这种饮食会导致所有小鼠品系的肝损伤;然而,肝脏中与 NAFLD 相关的病理形态变化的程度是品系特异性的,A/J、C57BL/6J 和 C3H/HeJ 小鼠的敏感性最低,WSB/EiJ 小鼠的敏感性最高。肝脏的形态变化伴随着肝和血浆 miRNA 水平的差异。循环 miR-34a、miR-122、miR-181a、miR-192 和 miR-200b 的水平与 NAFLD 特异性的肝病理形态特征的严重程度显著相关,其中与 miR-34a 的相关性最强。这些观察结果表明,miRNA 的血浆水平可作为非侵入性监测与 NAFLD 相关的肝损伤程度和 NAFLD 易感性的生物标志物。

相似文献

3
MicroRNA changes, activation of progenitor cells and severity of liver injury in mice induced by choline and folate deficiency.
J Nutr Biochem. 2016 Feb;28:83-90. doi: 10.1016/j.jnutbio.2015.10.001. Epub 2015 Oct 21.
8
Circulating microRNA 122 in the methionine and choline-deficient mouse model of non-alcoholic steatohepatitis.
J Appl Toxicol. 2014 Jun;34(6):726-32. doi: 10.1002/jat.2960. Epub 2013 Nov 12.

引用本文的文献

2
Role of extracellular vesicles in nonalcoholic fatty liver disease.
Front Endocrinol (Lausanne). 2023 Jul 18;14:1196831. doi: 10.3389/fendo.2023.1196831. eCollection 2023.
3
Significance of MiRNA-34a and MiRNA-192 as a risk factor for nonalcoholic fatty liver disease.
J Genet Eng Biotechnol. 2023 Feb 9;21(1):13. doi: 10.1186/s43141-023-00467-z.
4
Exosomal microRNAs and Progression of Nonalcoholic Steatohepatitis (NASH).
Int J Mol Sci. 2022 Nov 4;23(21):13501. doi: 10.3390/ijms232113501.
5
Pro-Neurotensin as a Potential Novel Diagnostic Biomarker for Detection of Nonalcoholic Fatty Liver Disease.
Diabetes Metab Syndr Obes. 2022 Jun 22;15:1935-1943. doi: 10.2147/DMSO.S365147. eCollection 2022.
6
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review.
Mol Ther Nucleic Acids. 2022 Feb 11;27:1191-1224. doi: 10.1016/j.omtn.2022.02.005. eCollection 2022 Mar 8.
7
Non-Coding RNAs: Novel Players in Insulin Resistance and Related Diseases.
Int J Mol Sci. 2021 Jul 19;22(14):7716. doi: 10.3390/ijms22147716.

本文引用的文献

1
Circulating microRNAs as potential markers of human drug-induced liver injury.
Hepatology. 2011 Nov;54(5):1767-76. doi: 10.1002/hep.24538.
2
Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease.
PLoS One. 2011;6(8):e23937. doi: 10.1371/journal.pone.0023937. Epub 2011 Aug 23.
3
Human fatty liver disease: old questions and new insights.
Science. 2011 Jun 24;332(6037):1519-23. doi: 10.1126/science.1204265.
4
Progression from isolated steatosis to steatohepatitis and fibrosis in nonalcoholic fatty liver disease.
Clin Res Hepatol Gastroenterol. 2011 Jan;35(1):23-8. doi: 10.1016/j.gcb.2010.06.004.
5
Subspecific origin and haplotype diversity in the laboratory mouse.
Nat Genet. 2011 May 29;43(7):648-55. doi: 10.1038/ng.847.
6
MicroRNA expression in the livers of inbred mice.
Mutat Res. 2011 Sep 1;714(1-2):126-33. doi: 10.1016/j.mrfmmm.2011.05.007. Epub 2011 May 14.
7
Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection.
Am J Gastroenterol. 2011 Sep;106(9):1663-9. doi: 10.1038/ajg.2011.161. Epub 2011 May 24.
9
Non-alcoholic fatty liver disease: a massive problem.
Clin Med (Lond). 2011 Apr;11(2):176-8. doi: 10.7861/clinmedicine.11-2-176.
10
Endpoints and clinical trial design for nonalcoholic steatohepatitis.
Hepatology. 2011 Jul;54(1):344-53. doi: 10.1002/hep.24376.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验